Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 6 % of short-term debt in 2024; threshold 65 %.
Financials
Financial year 2024
BioScientific Group from Wavre, company number BE0739510875, closed financial year 2024 with a result of € -100,555 after tax. For that financial year BioScientific Group recorded a gross margin of € 33,216 and equity of € 3.9 million. Compared with financial year 2024, the result moved from € 1.2 million to € -100,555. The company made a loss. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on September 30, 2025.
€ 3.9 million
▼ 4% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -100,555
▼ still € 1.2 million profit in 2024
Profit after tax over the fiscal year.
€ 145,698
▲ 30% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 3.4 million.
Debts at end 2024
€ 4.5 million
▼ 30% vs 2024
Loans from banks and other lenders, long and short.
€ 38,274
▼ 11% vs 2024
Supplier invoices still open on the last day of the fiscal year.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2024 | Change 2024 → 2024 | |
|---|---|---|---|---|---|
| Gross margin | € 217,586 | € 78,879 | € -9,305 | € 33,216 | ▲ € 42,521 |
| Profit after taxes | € 420,020 | € 1,825,278 | € 1,211,124 | € -100,555 | ▼ € 1.3 million |
| Equity | € 1,070,383 | € 2,895,661 | € 4,106,784 | € 3,943,383 | ▼ 4% |
| Total debts | € 6,578,705 | € 4,776,414 | € 9,621,706 | € 9,723,702 | ▲ 1% |
| Cash | € 123,267 | € 112,568 | € 112,264 | € 145,698 | ▲ 30% |
| Retained profit | € 570,383 | € 2,395,661 | € 3,606,784 | € 3,443,383 | ▼ 5% |
| Dividend | € 0 | € 0 | € 0 | € 62,847 | |
| Bank debt | € 4,978,471 | € 3,829,103 | € 6,441,387 | € 4,489,245 | ▼ 30% |
| Balance sheet total | € 7,649,088 | € 7,672,075 | € 13,728,490 | € 13,667,085 |
Key figures of BioScientific Group, fiscal years 2022 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.
What happened to BioScientific Group?
What happened at BioScientific Group in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2024: profit of € 1.2 million (▼ 34% vs 2023). filed late Source: NBB ↗
- New establishment in Wavre. KBO
- Lead Ventures SRL became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 420,020 profit in 2022 to € 100,555 loss in 2024.
Paid € 25,643 in corporate taxes since 2022.
Best year ever: 2023, with € 1.8 million profit.
Paid out € 62,847 in dividends to the owners in total.
A new publication or filing at BioScientific Group? We notify you, reason included.
Follow BioScientific GroupDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind BioScientific Group is Lead Ventures SRL. It owns 100% of Barré and 100% of R-Concept itself.
Directors
According to the 2024 annual accounts
Director · represented by Javier MARTINEZ
Also active at: IDEATEC, COPIA Invest SRL
since 2019
Establishments
Establishment units
Physical locations of this company
Avenue Zénobe Gramme 38
1300 Wavre
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0739.510.875
- VAT number
- BE 0739.510.875
- Registered office
- Avenue Zénobe Gramme 38, 1300 Wavre
- Names & denominations
- BioScientific Group · BSG
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 12 December 2019
- Peppol
- Active · Active since 30 Jun 2026
- Contact
- [email protected]
- Activities · NACE
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering